Skip to Content

KLX 171 (Fenofibrate 160 mg)

Pill with imprint KLX 171 is White, Round and has been identified as Fenofibrate 160 mg. It is supplied by Karalex Pharma.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 160 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KLX 171

Fenofibrate 160 mg KLX 171
Fenofibrate 160 mg KLX 171
Fenofibrate 160 mg KLX 171

Fenofibrate

Imprint
KLX 171
Strength
160 mg
Color
White
Size
12.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Karalex Pharma
National Drug Code (NDC)
42043-0171
Inactive Ingredients
betadex, silicon dioxide, calcium phosphate dihydrate dibasic, docusate sodium, sodium benzoate, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.